A novel lentiviral vector targets gene transfer into human hematopoietic stem cells in marrow from patients with bone marrow failure syndrome and in vivo in humanized mice
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel lentiviral vector targets gene transfer into human hematopoietic stem cells in marrow from patients with bone marrow failure syndrome and in vivo in humanized mice
Authors
Keywords
-
Journal
BLOOD
Volume 119, Issue 5, Pages 1139-1150
Publisher
American Society of Hematology
Online
2011-11-24
DOI
10.1182/blood-2011-04-346619
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Measles Virus Glycoprotein-Pseudotyped Lentiviral Vector-Mediated Gene Transfer into Quiescent Lymphocytes Requires Binding to both SLAM and CD46 Entry Receptors
- (2011) C. Frecha et al. JOURNAL OF VIROLOGY
- Stem Cell Gene Therapy for Fanconi Anemia: Report from the 1st International Fanconi Anemia Gene Therapy Working Group Meeting
- (2011) Jakub Tolar et al. MOLECULAR THERAPY
- Impact of interactions of cellular components of the bone marrow microenvironment on hematopoietic stem and progenitor cell function
- (2010) B. R. Chitteti et al. BLOOD
- Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage
- (2010) A. Tulpule et al. BLOOD
- Preclinical and clinical progress in hemophilia gene therapy
- (2010) Janka Mátrai et al. CURRENT OPINION IN HEMATOLOGY
- Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
- (2010) Marina Cavazzana-Calvo et al. NATURE
- Targeted gene delivery to CD117-expressing cells in vivo with lentiviral vectors co-displaying stem cell factor and a fusogenic molecule
- (2009) Steven Froelich et al. BIOTECHNOLOGY AND BIOENGINEERING
- Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors
- (2009) C. Frecha et al. BLOOD
- Targeted transduction of CD34+ hematopoietic progenitor cells in nonpurified human mobilized peripheral blood mononuclear cells
- (2009) Min Liang et al. JOURNAL OF GENE MEDICINE
- Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott–Aldrich Syndrome in Preclinical Models
- (2009) Francesco Marangoni et al. MOLECULAR THERAPY
- Lentiviral-mediated Genetic Correction of Hematopoietic and Mesenchymal Progenitor Cells From Fanconi Anemia Patients
- (2009) Ariana Jacome et al. MOLECULAR THERAPY
- Protection of Stem Cell-Derived Lymphocytes in a Primate AIDS Gene Therapy Model after In Vivo Selection
- (2009) Grant D. Trobridge et al. PLoS One
- Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
- (2009) N. Cartier et al. SCIENCE
- In vivo proliferation advantage of genetically corrected hematopoietic stem cells in a mouse model of Fanconi anemia FA-D1
- (2008) P. Rio et al. BLOOD
- Strategies for Targeting Lentiviral Vectors
- (2008) Cecilia Frecha et al. CURRENT GENE THERAPY
- Improved lentiviral vectors for Wiskott–Aldrich syndrome gene therapy mimic endogenous expression profiles throughout haematopoiesis
- (2008) C Frecha et al. GENE THERAPY
- Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation
- (2008) Keith W. Orford et al. NATURE REVIEWS GENETICS
- In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of -thalassemia
- (2008) A. Miccio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started